RhuMab-E25

· Duke University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RhuMab-E25, covering 2009-10-21 to 2009-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma [Phase 3]